Dr. Satoshi Furukawa, MD

Cardiovascular Surgery  ·  
Male  ·  
Age 60
(9)
Insurances Accepted  ·  Save
Dr. Satoshi Furukawa, MD
Dr. Satoshi Furukawa, MD is a cardiovascular surgery specialist in Philadelphia, PA and has been practicing for 25 years. He graduated from University Of Pennsylvania School Of Medicine in 1984 and specializes in cardiovascular surgery.

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

800 Walnut St Fl 19

Philadelphia, PA 19107

Contact Information

(215) 829-8713

Dr. Satoshi Furukawa, MD

Dr. Satoshi Furukawa, MD

Accepted insurance

  • Aetna
  • Amerihealth
  • Blue Cross Blue Shield
  • Capital Blue Cross
  • Cigna
  • Coventry Health Care
  • First Health (Coventry Health Care)
  • Geisinger Health Plan
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana
  • QualCare

*Please verify this information when scheduling an appointment.

Background Check

Healthgrades does not collect malpractice information for Pennsylvania
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Furukawa's experience treating your condition or procedure

Dr. Furukawa's Top Procedures and Conditions

Treatment Frequency
Coronary Artery Disease (CAD)
normal
normal

Treatment Frequency

Dr. Furukawa treats Coronary Artery Disease (CAD) more than 74% of his peers

Dr. Furukawa treats this condition more than 74% of his peers

Rating Includes other areas of care:

  • Coronary Artery Calcification
  • Coronary Artery Disease, Autosomal Dominant 1
  • Coronary Artery Disease, Autosomal Dominant 2
Coronary Artery Bypass Graft (CABG) Surgery
normal
normal

Treatment Frequency

Dr. Furukawa performs Coronary Artery Bypass Graft (CABG) Surgery more than 67% of his peers

Dr. Furukawa performs this procedure more than 67% of his peers

Rating Includes other areas of care:

  • Multi-Arterial Coronary Artery Bypass Graft (CABG) Surgery
  • Off-Pump Coronary Artery Bypass Graft (CABG) Surgery
Vascular Disease
normal
normal

Treatment Frequency

Dr. Furukawa treats Vascular Disease more than 67% of his peers

Dr. Furukawa treats this condition more than 67% of his peers

Dr. Furukawa's conditions and procedures:

Ablation for Treatment of Cardiac Arrhythmias
Abscess or Cyst Drainage or Aspiration
Abscess or Fluid Incision and Drainage
Aneurysm
Angina and Acute Coronary Syndrome
Aortic Aneurysm
Aortic Dissection
Aortic Ectasia
Aortic Repair, Open or Repair of Arterial Aneurysm, Open
Aortic Stenosis
Aortic Valve Disease
Aortic Valve Regurgitation
Aortic Valve Replacement
Aortic Valve Surgery
Arrhythmias
Atrial Conduits for Surgical Revascularization
Atrial Fibrillation
Atrial Flutter
Benign Tumor
Bullectomy
Cancer
Cardiac Catheterization (incl. Coronary Angiography)
Cardiac Electrophysiology
Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Cardiomegaly
Cardiomyopathy
Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
Carotid Artery Disease
Chest CT (incl. Heart and Lungs)
Congenital Aortic Valve Disorders
Congenital Heart Defects
Congenital Heart Disease
Congestive Heart Failure
Coronary Angioplasty, Atherectomy and Stent
Coronary Artery Bypass Graft (CABG) Surgery
Coronary Artery Disease (CAD)
Endocarditis
Head and Neck Cancer
Head and Neck Surgery
Heart Attack (Acute Myocardial Infarction)
Heart Defect Repair
Heart Disease
Heart Surgery
Heart Transplant
Heart Tumors, Malignant
Impella Device
Long-Term Mechanical Circulatory Support
Lung Cancer
Lung Surgery
Lung Transplant
Lung Volume Reduction Surgery (LVRS)
Maze Procedure
Minimally Invasive Surgery
Mitral Valve Disease
Mitral Valve Regurgitation
Mitral Valve Repair
Mitral Valve Stenosis
Mitral Valve Surgery
Neuroendocrine Tumors
Off-Pump Coronary Artery Bypass Graft (CABG) Surgery
Pacemaker Insertion or Replacement
Patent Ductus Arteriosus
Pericardial Disease
Peripheral Arterial Aneurysm
Peripheral Arterial Aneurysm and Dissection
Peripheral Artery Catheterization
Port Placements or Replacements
Pulmonary Disease
Pulmonary Embolism
Resection of Cardiac Tumor
Rheumatic Aortic Valve Disorders
Septal Defect
Thoracentesis
Thoracoscopic Surgery
Thrombosis
Tracheal Surgery
Transplant Surgery
Tricuspid Valve Surgery
Valve Repair or Replacement (Aortic, Mitral, Tricuspid, and Pulmonary)
Vascular Disease
Vascular Surgical Procedure
Video-Assisted Thoracoscopic Surgery (VATS) or Thoracotomy

About Me

Biography

Dr. Satoshi Furukawa, MD is a cardiovascular surgery specialist in Philadelphia, PA and has been practicing for 25 years. He graduated from University Of Pennsylvania School Of Medicine in 1984 and specializes in cardiovascular surgery.

Specialties

  • Cardiovascular Surgery

Board Certifications

  • General Surgery
  • Thoracic Cardiovascular Surgery

Education

  • 1996
    Temple University Hospital
    Fellowship Hospital
    1996
  • 1993
    Hospital Of The University Of Pennsylvania
    Fellowship Hospital
    1993
  • 1993
    Hospital Of The University Of Philadelphia
    Residency Hospital
    1993
  • 1991
    University Of Pennsylvania Health System
    Residency Hospital
    1991
  • 1987
    Hospital Of The University Of Pennsylvania
    Residency Hospital
    1987
  • 1985
    Hospital Of The University Penn
    Internship Hospital
    1985
  • 1984
    University Of Pennsylvania School Of Medicine
    Medical School
    1984

Languages

  • Spanish
  • English

Awards

Dr. Furukawa's Reviews

Likelihood to recommend Dr. Furukawa

4.1

Based on 9 reviews

5 Stars
77.77777777777777%
(7)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
22.22222222222222%
(2)

Leave a review

How likely are you to recommend
Dr. Furukawa?
(Select your rating)
Average Wait Time
  • Under 10 minutes
Dr. Furukawa's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. Satoshi Furukawa, MD
Reply
Worst bedside manor ever. Only interested in convincing patient to have surgery. Leaves everything else to PA and NP who were both cold and impersonal.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. Satoshi Furukawa, MD?
Reply
He is amazing! Had any other doctor in my area operated on me I know I would not be here to write this compliment. His expertise and compassion are par excellent. Thank you from the bottom of my heart!
Was this helpful?
thumbs up icon option3
thumbs down icon option
×Post a ResponseAre you Dr. Satoshi Furukawa, MD?

Leave a review

How was your experience with Dr. Furukawa?

Locations

Penn Medicine - Department of Colon and Rectal Surgery

Insurance accepted

Accepted insurance can change. Please double-check when making an appointment.

Aetna
Aetna HMO
Choice Plus POS II
Select
Amerihealth
Personal Choice PPO
Blue Cross Blue Shield
Blue Card PPO
Capital Blue Cross
Cigna
Cigna HMO
Cigna PPO
Open Access Plus
Coventry Health Care
Coventry Health America PPO
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
Geisinger Health Plan
Horizon Blue Cross Blue Shield of New Jersey
Direct Access
Horizon Blue Cross Blue Shield HMO
Horizon Blue Cross Blue Shield POS
Horizon Blue Cross Blue Shield PPO
Humana
Choice Care PPO
QualCare
QualCare HMO
QualCare PPO

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Furukawa treats patients.

Learn more

Pennsylvania Hospital

Philadelphia, PA